Advanced search
Publication Cover
International Journal of Circumpolar Health Volume 75, 2016 - Issue 1
Submit an article Journal homepage
1,011
Views
9
CrossRef citations to date
0
Altmetric
Original Research Articles

Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983–2012

Prabhu P. GounderArctic Investigations ProgramDivision of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, U.S. Centers for Disease Control and Prevention (CDC), Anchorage, AK, USACorrespondence[email protected]
,
Lisa R. BulkowArctic Investigations ProgramDivision of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, U.S. Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA
,
Martin I. MeltzerHealth Economics and Modeling UnitDivision of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA
,
Michael G. BruceArctic Investigations ProgramDivision of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, U.S. Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA
,
Thomas W. HennessyArctic Investigations ProgramDivision of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, U.S. Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA
,
Mary SnowballLiver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA
,
Philip R. SpradlingDivision of Viral HepatitisNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention Centers for Disease Control and Prevention, Atlanta, GA, USA
,
Bishwa B. AdhikariHealth Economics and Modeling UnitDivision of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA
&
Brian J. McMahonArctic Investigations ProgramDivision of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, U.S. Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA;Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA
 show all
Article: 31115 | Received 25 Jan 2015, Accepted 02 May 2016, Published online: 18 May 2016

References

  • World Health Organization. Hepatitis B vaccines. WHO position paper. 2009; Geneva, Switzerland: World Health Organization. 405–20.
  • Simonetti J, Bulkow L, McMahon BJ, Homan C, Snowball M, Negus S, etal. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology. 2010; 51: 1531–7. [PubMed Abstract].
  • Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53: 1020–2. [PubMed Abstract] [PubMed CentralFull Text].
  • Lederle FA, Pocha C. Screening for liver cancer: the rush to judgment. Ann Intern Med. 2012; 156: 387–9. [PubMed Abstract].
  • Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009; 50: 661–2. [PubMed Abstract].
  • McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med. 1990; 150: 1051–4. [PubMed Abstract].
  • McMahon BJ, Rhoades ER, Heyward WL, Tower E, Ritter D, Lanier AP, etal. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives. Lancet. 1987; 2: 1134–6. [PubMed Abstract].
  • Kelly J, Schade T, Starkey B, White S, Ashokkumar R, Lanier A 2012; Anchorage, AK: Alaska Native Tribal Health Consortium, Alaska Native Epidemiology Center. Cancer in Alaska. 1969–2008 40-year report.
  • Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, etal. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334: 693–9. [PubMed Abstract].
  • Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, etal. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology. 2009; 137: 110–8. [PubMed Abstract] [PubMed CentralFull Text].
  • Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, etal. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009; 30: 37–47. [PubMed Abstract].
  • Singal AG, Conjeevaram HS, Volk ML, Fu S, Fontana RJ, Askari F, etal. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev. 2012; 21: 793–9. [PubMed Abstract].
  • Haddix AC, Teutsch SM, Corso PS. Prevention effectiveness: a guide to decision analysis and economic evaluation. 2003; Oxford: Oxford University Press. 264. 2nd ed.
  • Qian MY, Yuwei JR, Angus P, Schelleman T, Johnson L, Gow P. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital. J Gastroenterol Hepatol. 2010; 25: 951–6. [PubMed Abstract].
  • Blumenthal D, Hsiao W. Privatization and its discontents – the evolving Chinese health care system. N Engl J Med. 2005; 353: 1165–70. [PubMed Abstract].
  • Lim MK, Yang H, Zhang T, Feng W, Zhou Z. Public perceptions of private health care in socialist China. Health Aff. 2004; 23: 222–34.
  • Luo Z, Xie Y, Deng M, Zhou X, Ruan B. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size. Eur J Gastroenterol Hepatol. 2011; 23: 695–700. [PubMed Abstract].
  • Zhang B, Yang B. Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer. J Med Screen. 1999; 6: 108–10. [PubMed Abstract].
  • Wong CR, Garcia RT, Trinh HN, Lam KD, Ha NB, Nguyen HA, etal. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci. 2009; 54: 2712–21. [PubMed Abstract].
  • Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004; 130: 417–22. [PubMed Abstract].
  • Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, etal. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001; 48: 251–9. [PubMed Abstract] [PubMed CentralFull Text].
  • Grosse SD. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res. 2008; 8: 165–78. [PubMed Abstract].
  • Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, etal. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol. 2001; 34: 570–5. [PubMed Abstract].
  • Sherman M. Alphafetoprotein: an obituary. J Hepatol. 2001; 34: 603–5. [PubMed Abstract].

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.